The tight junction protein occludin modulates blood–brain barrier integrity and neurological function after ischemic stroke in mice
Shintaro Sugiyama(The University of Osaka), Hideki Mochizuki(The University of Osaka)
Cited by 102
Related Papers
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease
|Scientific Reports|2019|100
Parkin-Mediated Protection of Dopaminergic Neurons in a Chronic MPTP-Minipump Mouse Model of Parkinson Disease
|Journal of Neuropathology & Experimental Neurology|2011|73
Accumulation of α-Synuclein Triggered by Presynaptic Dysfunction
|Journal of Neuroscience|2012|57
Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats
|Journal of Neuroinflammation|2021|50
Involvement of Mitochondria in Parkinson’s Disease
|International Journal of Molecular Sciences|2023|49